PACBIO Global Summit Presentation Video 2020
Reliable Nucleotide, InDel, and Structural Variant Detection in Diverse Populations
December 16, 2020
Never Miss an Update
Sign up and receive Discovery updates, blogs, and market news directly to your inbox.Subscribe Now
Presented by Shawn Levy, PhD (Discovery Life Sciences)
The ability to reliably detect and characterize the spectrum of sequence variants observed in the human genome is critical for understanding the role of mutation and variation in genetic risk and phenotype. Scaled CCS analysis on the Pacific Biosciences Sequel II platform supports efficient and reliable detection of complex and simple variants in diverse populations at high accuracy and enabling coverage.
Ask Your Questions
Have a question related to this presentation? Submit this form and we will get you answers.
To propel your projects with The Power of Discovery.™
Contact Us Today
Let us know about your project!